Transforming growth factor-β and oxidative stress mediate tachycardia-induced cellular remodelling in cultured atrial-derived myocytes

Cardiovascular Research

Volumn 91, Issue 1, 2011, Pages 62-70

  Yeh, Yung Hsin ^a   Kuo, Chi Tai ^a   Chan, Ting Hsiang ^a   Chang, Gwo Jyh ^b   Qi, Xiao Yan ^c   Tsai, Fengchun ^d   Nattel, Stanley ^c   Chen, Wei Jan ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Atrial fibrillation; Myosin; NADPH oxidase; Oxidative stress; TGF

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY;

ARTICLE; AUTOCRINE EFFECT; CONTROLLED STUDY; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MUSCLE FIBRIL; OXIDATIVE STRESS; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SINUS RHYTHM; TACHYCARDIA; UPREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES, NEUTRALIZING; ATRIAL FIBRILLATION; AUTOCRINE COMMUNICATION; BLOTTING, WESTERN; CARDIAC PACING, ARTIFICIAL; CASE-CONTROL STUDIES; CELL LINE; ENZYME INHIBITORS; FLUORESCENT ANTIBODY TECHNIQUE; FREE RADICAL SCAVENGERS; HEART ATRIA; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MYOCYTES, CARDIAC; MYOFIBRILS; NADPH OXIDASE; OXIDATIVE STRESS; PARACRINE COMMUNICATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TACHYCARDIA, SUPRAVENTRICULAR; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 79958791470     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr041     Document Type: Article

References (38)

1. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002;54:230-246. (Pubitemid 34327903)
2. Nattel S, Brurstein B, Dobrev D. Atrial remodeling and atrial fibrillation. Circ-Arrhythmia Elec 2008;1:62-73.
3. Ausma J, Wijffels M, Thone F,Wouters L, Allessie M, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 1997;96: 3157-3163. (Pubitemid 27500121)
4. Corradi D, Callegari S, Maestri R, Benussi S, Alfieri O. Structural remodeling in atrial fibrillation. Nat Clin Pract Card 2008;5:782-796.
5. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-988.
6. Kim YM, Guzik TJ, Zhang YH, Zhang MH, Kattach H, Ratnatunga C et al. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res 2005;97:629-636. (Pubitemid 41416331)
7. Dudley SC Jr, Hoch NE, McCann LA, Honeycutt C, Diamandopoulos L, Fukai T et al. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation 2005;112: 1266-1273. (Pubitemid 41268651)
8. Adam O, Frost G, Custodis F, Sussman MA, Schafers HJ, Bohm M et al. Role of Rac1 GTPase activation in atrial fibrillation. J Am Coll Cardiol 2007;50:359-367. (Pubitemid 47064499)
9. Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 2007; 115:135-143. (Pubitemid 46136515)
10. Kim YM, Kattach H, Ratnatunga C, Pillai R, Channon KM, Casadei B. Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 2008;51:68-74.
11. Tsai CT, Lin JL, Lai LP, Lin CS, Huang SK. Membrane translocation of small GTPase Rac1 and activation of STAT1 and STAT3 in pacing-induced sustained atrial fibrillation. Heart Rhythm 2008;5:1285-1293.
12. ZhaoW, Zhao T, Chen Y, Ahokas RA, Sun Y. Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats. Mol Cell Biochem 2008;317:43-50.
13. Li S, Li X, Zheng H, Xie B, Bidasee KR, Rozanski GJ. Pro-oxidant effect of transforming growth factor-beta1 mediates contractile dysfunction in rat ventricular myocytes. Cardiovasc Res 2008;77:107-117. (Pubitemid 351195150)
14. Bujak M, Frangogiannis NG. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 2007;74:184-195. (Pubitemid 46517504)
15. Burstein B, Nattel S. Atrial fibrosis: mechanism and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008; 51:802-809. (Pubitemid 351260071)
16. Burstein B, Qi XY, Yeh YH, Calderone A, Nattel S. Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: a novel consideration in atrial remodeling. Cardiovasc Res 2007;76:442-452. (Pubitemid 350007456)
17. Yang Z, Shen W, Rottman JN, Wilswo JP, Marray KT. Rapid stimulation causes electrical remodeling in cultured atrial myocytes. J Mol Cell Cardiol 2005;38:299-308. (Pubitemid 40215199)
18. Mace LC, Yermalitskaya LV, Yi Y, Yang Z, Morgan AM, Murray KT. Transcriptional remodeling of rapidly stimulated HL-1 atrial myocytes exhibits concordance with human atrial fibrillation. J Mol Cell Cardiol 2009;47:485-492.
19. Brundel BJ, Kampinga HH, Henning RH. Calpain inhibition prevents pacing-induced cellular remodeling in a HL-1 myocyte model for atrial fibrillation. Cardiovasc Res 2004;62:521-528. (Pubitemid 38648966)
20. Ke L, Qi XY, Dijkhuis AJ, Chartier D, Nattel S, Henning RH et al. Calpain mediates cardiac troponin degradation and contractile dysfunction in atrial fibrillation. J Mol Cell Cardiol 2008;45:685-693.
21. Claycomb WC, Lanson NA Jr, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA 1998;95: 2979-2984. (Pubitemid 28135840)
22. Burstein B, Libby E, Calderone A, Nattel S. Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrialventricular remodeling differences. Circulation 2008;117:1630-1641. (Pubitemid 351482606)
23. Tsai CT, Wang DL, Chen WP, Hwang JJ, Hsieh CS, Hsu KL et al. Angiotensin II increases expression of alpha1C subunit of L-type calcium channel through a reactive oxygen species and cAMP response element-binding protein-dependent pathway in HL-1 myocytes. Circ Res 2007;100:1476-1485. (Pubitemid 46834760)
24. Chen WJ, Pang JHS, Lin KH, Lee DY, Hsu LA, Kuo CT. Propylthiouracil, independent of its antithyroid effect, promotes VSMC differentiation via PTEN induction. Basic Res Cardiol 2010;105:19-28.
25. Shi Y, Massague J. Mechanisms of TGF-b signaling from cell membrane to the nucleus. Cell 2003;113:685-700. (Pubitemid 36724933)
26. Akki A, Zhang M, Murdoch C, Brewer A, Shah AM. NADPH oxidase signaling and cardiac myocyte function. J Am Coll Cardiol 2009;47:15-22.
27. Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFbeta activation. J Cell Sci 2003;116:217-224. (Pubitemid 36163863)
28. Cucoranu I, Clempus R, Dikalova A, Phelan PJ, Ariyan S, Dikalov S et al. NADPH oxidase 4 mediates transforming growth factor-b1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res 2005;97:900-907. (Pubitemid 41552675)
29. Bondi CD, Manickam N, Lee DY, Block K, Gorin Y, Abboud HE et al. NADPH oxidase mediates TGFb1-induced activation of kidney myofibroblasts. J Am Soc Nephrol 2010; 21:93-102.
30. Brundel BJ, Ausma J, van Gelder IC, Van Der Want JJ, van Gilst WH, Crijns HJ et al. Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation. Cardiovasc Res 2002;54:380-389. (Pubitemid 34327916)
31. Corradi D, Callegari S, Benussi S, Maestri R, Pastori P, Nascimbene S et al. Myocyte changes and their left atrial distribution in patients with chronic atrial fibrillation related to mitral valve disease. Hum Pathol 2005;36:1080-1089. (Pubitemid 41443259)
32. Muller FU, Lewin G, Baba HA, Boknik P, Fabritz L, Kirchhefer U et al. Heart-directed expression of a human cardiac isoform of cAMP-response element modulator in transgenic mice. J Biol Chem 2005;280:6906-6914. (Pubitemid 40341246)
33. Adam O, Lavall D, Theobald K, Hohl M, Grube M, Ameling S et al. Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation. J Am Coll Cardiol 2010;55:469-480.
34. Grieve DJ, Byrne JA, Siva A, Layland J, Johar S, Cave AC et al. Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload. J Am Coll Cardiol 2006;47: 817-826. (Pubitemid 43243107)
35. Chen CL, Lin JL, Lai LP, Pan CH, Huang SK, Lin CS. Altered expression of FHL1, CARP, TSC-22 and P311 provide insights into complex transcriptional regulation in pacing-induced atrial fibrillation. Biochim Biophys Acta 2007;1772:317-329. (Pubitemid 46275432)
36. Kim SK, Pak HN, Park JH, Ko KJ, Lee JS, Choi JI et al. Clinical serological predictors for the recurrence of atrial fibrillation after electrical cardioversion. Europace 2009;11: 1632-1638.
37. Verheule S, Sato T, Everett T, Engle SK, Otten D, von der Lohe MR et al. Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1. Cir Res 2004;94:1458-1465. (Pubitemid 38780318)
38. Wakili R, Yeh YH, Qi XY, Greiser M, Chartier D, Nishida K et al. Potential molecular mechanisms of atrial hypocontractility caused by atrial tachycardia remodeling in dogs. Circ-Arrhythmia Elec 2010;3:530-541.